gamma-L-Glutamyl-L-2-aminobutyrate

Metabolite details

Identifier

FUZOZPRKGAXGOB-WDSKDSINSA-N

InChI Key

FUZOZPRKGAXGOB-WDSKDSINSA-N

IUPAC name

(2S)-2-amino-5-[[(1S)-1-carboxypropyl]amino]-5-oxopentanoic acid

Preferred name

gamma-L-Glutamyl-L-2-aminobutyrate

INN name

—

Synonym

—

ChEBI

CHEBI:176875

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 21)
• Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 10)
• Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
• Multi-omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer

Observed in differential profiles

• Sham_vs_UIR
• Sham_vs_UIR
• LLIR_vs_Control
• Control_vs_Endometrial_Cancer